Aeon Biopharma, which is currently testing a botulinum toxin complex to treat migraines and other ailments, went public through a special purpose acquisition company, also known as a SPAC, on July 24.
An Irvine-based clinical-stage, biopharmaceutical company led by a former top Allergan executive is planning to go public via a special purpose acquisition company
Facial aesthetics, also known as facial cosmetic surgeries, are non-surgical operations intended to reduce the appearance of age-related changes in the.